0000950170-24-098810.txt : 20240819 0000950170-24-098810.hdr.sgml : 20240819 20240819203038 ACCESSION NUMBER: 0000950170-24-098810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240819 DATE AS OF CHANGE: 20240819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saito Chihiro CENTRAL INDEX KEY: 0002034025 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40656 FILM NUMBER: 241222376 MAIL ADDRESS: STREET 1: C/O TENAYA THERAPEUTICS, INC. STREET 2: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tenaya Therapeutics, Inc. CENTRAL INDEX KEY: 0001858848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813789973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-865-2066 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 500 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 ownership.xml 4 X0508 4 2024-08-15 false 0001858848 Tenaya Therapeutics, Inc. TNYA 0002034025 Saito Chihiro C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., 5TH FLOOR SOUTH SAN FRANCISCO CA 94080 false true false false SVP, Accounting and Fin. Ops. false Common Stock 2024-08-15 4 A false 25000 0 A 65604 D Common Stock 2024-08-16 4 S false 902 2.8945 D 64702 D Common Stock 2024-08-16 4 S false 654 2.8945 D 64048 D Common Stock 2024-08-16 4 S false 807 2.8945 D 63241 D Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock. The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on November 15, 2024, and 1/4th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested. Includes 57,772 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on October 15, 2022. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.79 to $3.02. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Includes 56,870 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023. Includes 56,216 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024. Includes 55,409 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact 2024-08-19